Regional Fascial Plane Blocks and Early Postoperative Complications in Reduction Mammaplasty: A Retrospective Cohort Study
摘要
Regional fascial plane blocks are widely used in breast surgery for postoperative analgesia. While analgesic benefits are established, their impact on early complications after reduction mammaplasty remains unclear.
ObjectiveTo evaluate the association between regional fascial plane block use and early postoperative complications following superior pedicle reduction mammaplasty.
MethodsThis retrospective cohort study included 144 consecutive patients undergoing primary bilateral superior pedicle reduction mammaplasty at a single tertiary center. Patients were grouped as block (n=64) or no-block (n=80). All blocks were performed postoperatively at the end of surgery. The primary outcome was a 30-day composite complication, defined as hematoma requiring reoperation, wound dehiscence, or surgical site infection. Multivariable logistic regression assessed the independent association between block use and complications.
ResultsOverall, 55 patients (38.2%) developed at least one early postoperative complication. The composite complication rate was higher in the block group than in the no-block group (46.9% vs. 31.3%); however, this difference did not reach statistical significance (p=0.060). In multivariable analysis, block use was not independently associated with complications, whereas total excision weight was the only significant predictor. Hematomas occurred only in the block group (7.8% vs. 0%, p=0.016).
ConclusionsRegional fascial plane block use was not independently associated with overall postoperative morbidity after adjustment. Although hematomas were observed only in the block group, the low event rate and non-randomized design preclude causal inference. However, a relevant increase in overall complication risk cannot be ruled out; therefore, further prospective studies are needed to clarify this relationship.
Level of Evidence IIIThis journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.